Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Docetaxel”

1,997 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,997 results

Testing effectiveness (Phase 2)WithdrawnNCT00256841
What this trial is testing

Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clinical Oncology Research Associates
Large-scale testing (Phase 3)Study completedNCT02604342
What this trial is testing

Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib

Who this might be right for
Non-small Cell Lung Cancer
Hoffmann-La Roche 119
Early research (Phase 1)Looking for participantsNCT07316686
What this trial is testing

Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Instituto do Cancer do Estado de São Paulo 18
Not applicableEnded earlyNCT00146029
What this trial is testing

Companion Pharmacogenetic Study to UMCC 9900/9901

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06732856
What this trial is testing

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmGastric (Stomach) Cancer
Asan Medical Center 57
Testing effectiveness (Phase 2)Ended earlyNCT00373204
What this trial is testing

Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)

Who this might be right for
Lung Cancer
Pharmacyclics LLC. 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464327
What this trial is testing

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Who this might be right for
Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company 450
Large-scale testing (Phase 3)UnknownNCT00030641
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Genta Incorporated
Testing effectiveness (Phase 2)UnknownNCT01131429
What this trial is testing

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

Who this might be right for
Neoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more
Chinese PLA General Hospital 60
Early research (Phase 1)Ended earlyNCT00313456
What this trial is testing

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel

Who this might be right for
TumorsProstate Cancer
Agennix 25
Early research (Phase 1)Study completedNCT02437370
What this trial is testing

Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer

Who this might be right for
Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterRecurrent Bladder CarcinomaRecurrent Urothelial Carcinoma of the Renal Pelvis and Ureter+6 more
University of California, Davis 32
Testing effectiveness (Phase 2)Looking for participantsNCT06488222
What this trial is testing

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Who this might be right for
Bladder Cancer
University of Florida 34
Testing effectiveness (Phase 2)Ended earlyNCT03764540
What this trial is testing

Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide

Who this might be right for
Metastatic Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 57
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT03089645
What this trial is testing

MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 39
Testing effectiveness (Phase 2)UnknownNCT01380275
What this trial is testing

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Who this might be right for
Sarcoma
National Cancer Center, Korea 35
Not applicableStudy completedNCT01004601
What this trial is testing

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Chang Gung Memorial Hospital 179
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07547592
What this trial is testing

Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma

Who this might be right for
Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site
Yonsei University 92
Testing effectiveness (Phase 2)Study completedNCT01107444
What this trial is testing

Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 180
Testing effectiveness (Phase 2)Study completedNCT00165464
What this trial is testing

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric CancerGE Junction Cancer
Dana-Farber Cancer Institute 54
Next Page